Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The eradication failure rate of standard triple therapy (proton pump inhibitor, clarithromycin, and amoxicillin) for Helicobacter pylori infection has increased owing to antibiotic resistance in Korea. We assessed whether Saccharomyces boulardii probiotic or broccoli sprout extract sulforaphane supplementation could increase the H. pylori eradication rate and/or reduce antibiotic-associated adverse events. Methods: A total of 217 patients with H. pylori-positive chronic gastritis or peptic ulcer disease were recruited. Clarithromycin resistance was assessed in all patients by testing for A2142G and A2143G point mutations in H. pylori 23S rRNA using a dual-priming polymerase chain reaction (PCR) oligonucleotide. Thirty-four patients (17.3%) were clarithromycin-resistant and were excluded from the study. Finally, 183 patients with infections not resistant to clarithromycin were randomly assigned to triple therapy only (group A, n = 61), triple therapy plus probiotics (group B, n = 61), or triple therapy plus sulforaphane (group C, n = 61) groups. CYP2C19 polymorphisms were examined at position G681A of exon 5 and G636A of exon 4 by PCR with restriction fragment length polymorphism (PCR-RFLP) analysis. H. pylori eradication was assessed by 13C-urea breath test 4 weeks after treatment completion. Results: The eradication rates were similar among the groups both in the intention- to-treat (A = 85.2%, B = 89.6%, and C = 81.6%) and per-protocol (A = 89.2%, B = 86.8%, and C = 96.3%) analyses. The frequencies of overall adverse events in the groups also did not differ (A vs. B: p = 0.574; A vs. C: p = 1.000). Conclusions: Probiotic or sulforaphane with triple therapy for H. pylori infection neither increased the eradication rate nor reduced the occurrence of adverse events.
Abstract
Background/Aims: The eradication failure rate of standard triple therapy (proton pump inhibitor, clarithromycin, and amoxicillin) for Helicobacter pylori infection has increased owing to antibiotic resistance in Korea. We assessed whether Saccharomyces boulardii probiotic or broccoli sprout extract sulforaphane supplementation could increase the H. pylori eradication rate and/or reduce antibiotic-associated adverse events. Methods: A total of 217 patients with H. pylori-positive chronic gastritis or peptic ulcer disease were recruited. Clarithromycin resistance was assessed in all patients by testing for A2142G and A2143G point mutations in H. pylori 23S rRNA using a dual-priming polymerase chain reaction (PCR) oligonucleotide. Thirty-four patients (17.3%) were clarithromycin-resistant and were excluded from the study. Finally, 183 patients with infections not resistant to clarithromycin were randomly assigned to triple therapy only (group A, n = 61), triple therapy plus probiotics (group B, n = 61), or triple therapy plus sulforaphane (group C, n = 61) groups. CYP2C19 polymorphisms were examined at position G681A of exon 5 and G636A of exon 4 by PCR with restriction fragment length polymorphism (PCR-RFLP) analysis. H. pylori eradication was assessed by 13C-urea breath test 4 weeks after treatment completion. Results: The eradication rates were similar among the groups both in the intention- to-treat (A = 85.2%, B = 89.6%, and C = 81.6%) and per-protocol (A = 89.2%, B = 86.8%, and C = 96.3%) analyses. The frequencies of overall adverse events in the groups also did not differ (A vs. B: p = 0.574; A vs. C: p = 1.000). Conclusions: Probiotic or sulforaphane with triple therapy for H. pylori infection neither increased the eradication rate nor reduced the occurrence of adverse events.
참고문헌 (30)
- McColl KE, "Clinical practice : Helicobacter pylori infection", N Engl J Med, 362, pp.1597~1604 (2010)
- Kim YS, "Epidemiology of Helicobacter pylori infection in Korea", Korean J Helicobacter Up Gastrointest Res, 11, pp.1~6 (2011)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009", Cancer Research and Treatment, 44(1), pp.11~24 (2012), 대한암학회
- 조동근, "Helicobacter pylori 제균율 변화와일차 제균에 영향을 미치는 임상 인자", 대한소화기학회지, 55(6), pp.368~375 (2010), 대한소화기학회
- 최유식, "Helicobacter pylori 일차 삼제 제균요법의 연도별 제균율 분석: 단일 기관의 최근 8년 성적", 대한소화기학회지, 48(3), pp.156~161 (2006), 대한소화기학회
- 김범진, "Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis", Journal of Korean Medical Science, 31(8), pp.1246~1253 (2016), 대한의학회
- Malfertheiner P, "Peptic ulcer disease", Lancet, 374, pp.1449~1461 (2009)
- Lee JW, "Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012", Helicobacter, 18, pp.206~214 (2013)
- Bell GD, "Experience with ‘triple’ anti-Helicobacter pylori eradication therapy : side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance", Aliment Pharmacol Ther, 6, pp.427~435 (1992)
- Tong JL, "Meta-analysis : the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy", Aliment Pharmacol Ther, 25, pp.155~168 (2007)
- Song MJ, "The effect of probiotics and mucoprotective agents on PPI-based triple therapy for eradication of Helicobacter pylori", Helicobacter, 15, pp.206~213 (2010)
- Onder Bekar, "Kefir Improves the Efficacy and Tolerability of Triple Therapy in Eradicating Helicobacter pylori", Journal of Medicinal Food, 14(4), pp.344~347 (2011), 한국식품영양과학회
- Szajewska H, "Meta-analysis : the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment", Aliment Pharmacol Ther, 32, pp.1069~1079 (2010)
- Guerrero-Beltran CE, "Protective effect of sulforaphane against oxidative stress : recent advances", Exp Toxicol Pathol, 64, pp.503~508 (2012)
- Brandenburg LO, "Sulforaphane suppresses LPS-induced inflammation in primary rat microglia", Inflamm Res, 59, pp.443~450 (2010)
- Zhang Y, "A major inducer of anticarcinogenic protective enzymes from broccoli : isolation and elucidation of structure", Proc Natl Acad Sci U S A, 89, pp.2399~2403 (1992)
- pyrene-induced stomach tumors, "Proc Natl Acad Sci U S A", 2002, 7610~7615
- 장영운, "The Effects of Broccoli Sprout Extract Containing Sulforaphane on Lipid Peroxidation and Helicobacter pylori Infection in the Gastric Mucosa", Gut and Liver, 9(4), pp.486~493 (2015), 거트앤리버 소화기연관학회협의회
- Occhialini A, "Macrolide resistance in Helicobacter pylori : rapid detection of point mutations and assays of macrolide binding to ribosomes", Antimicrob Agents Chemother, 41, pp.2724~2728 (1997)
- Andersson T, "Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects", Pharmacogenetics, 2, pp.25~31 (1992)
- Malfertheiner P, "Management of Helicobacter pylori infection-the Maastricht V", Florence Consensus Report, 2017, pp.66, 6~30
- Lee JY, "Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19genotype and antibiotic resistance", Dig Dis Sci, 59, pp.1235~1243 (2014)
- Wang ZH, "Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy", J Clin Gastroenterol, 47, pp.25~32 (2013)
- Dang Y, "The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy : a meta-analysis", PLoS One, 9, pp.e111030~ (2014)
- Nista EC, "Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment : randomized, double-blind, placebo controlled trial", Aliment Pharmacol Ther, 20, pp.1181~1188 (2004)
- Zou J, "Meta-analysis : Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication", Helicobacter, 14, pp.97~107 (2009)
- Sachdeva A, "Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication : a systematic review and meta-analysis of randomized-controlled trials", Eur J Gastroenterol Hepatol, 21, pp.45~53 (2009)
- Zheng X, "Lactobacillus-containing probiotic supplementation increases Helicobacter pylori eradication rate : evidence from a meta-analysis", Rev Esp Enferm Dig, 105, pp.445~453 (2013)
- Yanaka A, "Sulforaphane enhances protection and repair of gastric mucosa against oxidative stress in vitro, and demonstrates anti-inflammatory effects on Helicobacter pylori-infected gastric mucosae in mice and human subjects", Curr Pharm Des, 17, pp.1532~1540 (2011)
- Yanaka A, "Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans", Cancer Prev Res (Phila), 2, pp.353~360 (2009)